Le Lézard
Classified in: Science and technology, Business
Subject: VEN

Azimuth GRC Closes Series A With Investment from Detroit Venture Partners

JACKSONVILLE, Fla., Nov. 10, 2021 /PRNewswire/ -- Azimuth GRC, a compliance automation pioneer, today announced Detroit Venture Partners has joined its series A, bringing the total round to $6.3 million.

Detroit Venture Partners is the venture capital arm of Rock Ventures, a for-more-than-profit organization which is made up of nearly 100 separate businesses spanning fintech, sports, entertainment, real estate, startups and more.

"Azimuth's VALIDATOR product simplifies compliance with automated full-population testing, reducing cumbersome manual compliance activities to make an immediate impact in the mortgage and lending space. We are thrilled to partner with Rohin and the Azimuth team as they drive much-needed innovation in the regulatory tech space," said Jared Stasik, partner at Detroit Venture Partners.

The investment from DVP rounds out the company's series A, led by Mosaik Partners. The funds will help fuel the growth of the Azimuth team, product suite and go-to-market efforts. Azimuth GRC is the first and only company to codify every state and federal law on one platform and tie them directly to controls.

"2021 has been our year - from bringing on investors with the expertise in RegTech and mortgage to securing a new office space and a projected revenue growth of 300 percent," said Rohin Tagra, founder and CEO of Azimuth GRC. "Eliminating the arduous manual processes typically needed for regulatory compliance is our mission, and this capital helps us do that faster."

To learn more about Azimuth GRC, visit AzimuthGRC.com.

About Azimuth GRC
Azimuth GRC revolutionizes the world of regulatory compliance by being the first and only company to codify every state and federal law on one platform, changing the culture of compliance by taking manual compliance work done on paper spreadsheets and automating it. Led by founder and CEO Rohin Tagra, Azimuth GRC is the only company bold enough to offer VALIDATOR, a software that provides daily automated tests of an entire portfolio to determine compliance with all applicable laws and regulations.

About Detroit Venture Partners
Since 2010, Detroit Venture Partners has been committed to backing and founding early stage tech companies that we believe move the world forward. DVP was founded by Dan Gilbert, Rocket Mortgage Founder and Chairman, with a vision to grow Detroit's entrepreneurial community. We partner with visionary founders and help our portfolio companies succeed by leveraging the more than 100 companies within the Rock Family of Companies, including Rocket Mortgage, Cleveland Cavaliers, Bedrock, and StockX.

Media Contact
Emylee Eyler



These press releases may also interest you

at 08:10
Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software, announced today that it has raised $150 million in Series B financing to accelerate development of its core algorithmic...

at 08:10
Bay Area biotech company renegade.bio today announced the opening of its new lab in Berkeley, California. The lab will expand clinical diagnostic capabilities enabling on-time, precision medicine. In addition, the lab will host research and...

at 08:10
Shiftboard, a global leader in enterprise workforce scheduling, today announced that it won a coveted gold Brandon Hall Group Excellence in Technology Award for "best advance in time and labor management." "We're thrilled to be recognized by the...

at 08:10
Ekata, a global leader in digital identity verification, today expanded its account opening solutions to help online businesses worldwide quickly identify and flag risky account sign-ups. Powered by a proprietary data set and machine learning,...

at 08:10
Clari, the revenue operations leader, today announced it has closed on a $225 million Series F round, raising the company's total valuation to more than $2.6 billion. The new funding follows Clari's $150 million Series E round in March 2021, bringing...

at 08:10
Qpex Biopharma, Inc., (Qpex) a clinical-stage biopharmaceutical company discovering and developing innovative anti-infective therapies, today announced continued clinical progress of its entire pipeline and highlights the company's strategic...

News published on 10 november 2021 at 09:00 and distributed by: